These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12090443)

  • 21. Administration of clozapine and excessive elevated serum triglycerides: a case report.
    Kontoangelos K; Economou M; Kiriaki P; Michalis V; Papadimitriou GN
    J Clin Psychopharmacol; 2014 Jun; 34(3):387-8. PubMed ID: 24717253
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid and lipoprotein profiles in Ethiopian patients with diabetes mellitus.
    Siraj ES; Seyoum B; Saenz C; Abdulkadir J
    Metabolism; 2006 Jun; 55(6):706-10. PubMed ID: 16713427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
    Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
    Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Type 2 diabetes and dyslipidemia. Side effects of "Atypical" neuroleptics?].
    Wetterling T
    Med Klin (Munich); 2003 Jul; 98(7):364-7. PubMed ID: 12937901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.
    Miller MJ; Molla PM
    Arch Psychiatr Nurs; 2005 Feb; 19(1):30-4. PubMed ID: 15765369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs.
    Paz E; Hermida J; Bouzas L; Brenlla J; Tutor JC
    Clin Biochem; 2008 Aug; 41(12):1002-7. PubMed ID: 18474233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    Nord J Psychiatry; 2017 Oct; 71(7):496-502. PubMed ID: 28632422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased dyslipidemia in schizophrenic outpatients using new generation antipsychotics.
    Leitão-Azevedo CL; Guimarães LR; de Abreu MG; Gama CS; Lobato MI; Belmonte-de-Abreu PS
    Braz J Psychiatry; 2006 Dec; 28(4):301-4. PubMed ID: 17242810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients.
    Lappin JM; Wijaya M; Watkins A; Morell R; Teasdale S; Lederman O; Rosenbaum S; Dick S; Ward P; Curtis J
    Schizophr Res; 2018 Sep; 199():367-373. PubMed ID: 29486959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic ketoacidosis and severe hypertriglyceridaemia as a consequence of an atypical antipsychotic agent.
    Hepburn K; Brzozowska MM
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27507689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of dyslipidemia (hypertriglyceridemia and hypercholesterolemia) in patients treated with the new generation of antipsychotic drugs compared to conventional therapy.
    Sadibašić B; Macić-Džanković A; Šabić A; Torlak B; Lastrić G; Ćustović A
    Med Glas (Zenica); 2014 Aug; 11(2):350-5. PubMed ID: 25082252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental hypertriglyceridaemia and hypercholesterolaemia in rats.
    Pérez C; Canal JR; Romero A; Torres MD
    Acta Physiol Hung; 1999; 86(1):57-68. PubMed ID: 10755170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dyslipidemia in obesity: pathogenetic considerations and our experience].
    Pandolfi C; Pellegrini L; Mercantini F; Sbalzarini G; Filippi C
    Minerva Med; 1993 Mar; 84(3):113-7. PubMed ID: 8492962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine-associated elevation of plasma cholinesterase.
    Wiltfang J; Schenk-Daprá B; Stiens G; Bleich S; Bandelow B; Müller P; Niedmann PD; Armstrong VW; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 2001 Dec; 251(6):269-71. PubMed ID: 11881840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study.
    Hyde N; Dodd S; Venugopal K; Purdie C; Berk M; O'Neil A
    Curr Drug Saf; 2015; 10(2):125-31. PubMed ID: 25986036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point prevalence of diabetes, obesity, hyperlipidaemia, hypertension and smoking in outpatients on clozapine.
    Feeney L; Kelly F; Lee J; Kelly E; McLaughlin S; O'Boyle JH
    Ir J Psychol Med; 2007 Jun; 24(2):59-61. PubMed ID: 30290552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.